Biotechnology · San Diego, California, United States
$0.99
+0.92% (+$0.01)2026-07-09
Smart-Money SignalNeutral · 53/100— Insiders are net buyers over 90 days ($21K, 1 buy vs 0 sales)
Revenue$0
Net Income-$58.1M
EPS$-1.68
Market Cap$34.8M
Price Performance
Historical data including institutional events
Company Profile
J
Justin File
CEO & Executive Director
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer.
The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025.
Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
